Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 19.73 is 80% above its 5-year average of 10.96, near the high end of its 5-year range (3.72–24.23).
As of the fiscal period ended Tuesday, June 30, 2026. 55.81% above its 12-month average of 12.66.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 19.73.
CURRENT RATIO
19.73
CURRENT RATIO AVG TTM
12.66
CURRENT RATIO AVG 3Y
9.41
CURRENT RATIO AVG 5Y
10.96
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+55.81%
CURRENT VS 3Y AVG
+109.68%
CURRENT VS 5Y AVG
+80.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.39
median of 619 covered companies
CURRENT VS SECTOR MEDIAN
+482.03%
vs the sector median at left
Damora Therapeutics, Inc.
Market Cap
$1.13B
Current Ratio
19.73
TTM Avg
12.66
3Y Avg
9.41
5Y Avg
10.96
Market Cap
$1.13B
Current Ratio
33.10
TTM Avg
10.19
3Y Avg
10.19
5Y Avg
10.19
Market Cap
$1.12B
Current Ratio
2.40
TTM Avg
3.54
3Y Avg
3.31
5Y Avg
3.13
Market Cap
$1.09B
Current Ratio
11.59
TTM Avg
21.25
3Y Avg
14.51
5Y Avg
14.51
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.13B | 19.73 | 12.66 | 9.41 | 10.96 |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 33.10 | 10.19 | 10.19 | 10.19 |
| Kardigan, Inc. (KARD)vs › | $1.19B | 8.72 | 9.20 | 9.20 | 9.20 |
| Harrow Health, Inc. (HROW)vs › | $1.11B | 2.24 | 2.14 | 3.36 | 3.91 |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 2.40 | 3.54 | 3.31 | 3.13 |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 1.38 | 3.96 | 6.78 | 9.79 |
| Nektar Therapeutics (NKTR)vs › | $1.17B | 10.42 | 4.62 | 5.92 | 7.14 |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | 11.59 | 21.25 | 14.51 | 14.51 |
| IRadimed Corporation (IRMD)vs › | $1.09B | 9.46 | 8.41 | 7.63 | 9.11 |
| MannKind Corporation (MNKD)vs › | $1.19B | 1.72 | 2.49 | 3.01 | 2.95 |
Current Ratio
19.73
Quick Ratio
19.73
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 19.73 |
| 2026-03-31 | 22.48 |
| 2025-12-31 | 12.98 |
| 2025-09-30 | 3.73 |
| 2025-06-30 | 4.39 |
| 2025-03-31 | 8.64 |
| 2024-12-31 | 14.07 |
| 2024-09-30 | 8.68 |
| 2024-06-30 | 6.79 |
| 2024-03-31 | 7.07 |
| 2023-12-31 | 6.31 |
| 2023-09-30 | 3.75 |
| 2023-06-30 | 3.72 |
| 2023-03-31 | 4.06 |
| 2022-12-31 | 5.75 |
| 2022-09-30 | 8.04 |
| 2022-06-30 | 10.98 |
| 2022-03-31 | 13.45 |
| 2021-12-31 | 24.23 |
| 2021-09-30 | 18.63 |
| 2021-06-30 | 22.65 |
| 2021-03-31 | 21.10 |
| 2020-12-31 | 30.42 |
| 2020-09-30 | 11.53 |
| 2020-03-31 | 0.00 |
| 2019-09-30 | 0.00 |
